Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/14/2780571/0/en/Qualigen-Therapeutics-Provides-Corporate-Update-for-Third-Quarter-and-To-Date-2023.html

CARLSBAD, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today provides a corporate update for the third quarter ending September 30, 2023 and to date:

Read more at globenewswire.com

Related news for (QLGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.